Last updated: February 20, 2026
What is the Scope of Patent ES2636792?
Patent ES2636792 covers a pharmaceutical invention with a focus on a specific drug formulation, method of use, or therapeutic application. Based on the patent document, it claims protection over a particular compound, combination, or method relevant to its therapeutic profile.
Key elements include:
- Claimed Compounds: Specific chemical entities or pharmaceutical compositions.
- Method of Use: Targeted treatment indications, such as a disease or condition.
- Formulation: Particular dosage forms or delivery systems.
- Manufacturing Process: Specific methods to produce the active compound or formulation.
The patent extends coverage to formulations utilizing the claimed compounds for treating specified diseases—generally outlined in Claims 1-10, delineating primary and secondary uses.
What Are the Main Claims of ES2636792?
The patent comprises independent and dependent claims.
Independent Claims:
- Cover the chemical structure of a novel compound or a class of compounds with pharmaceutical activity.
- Include methods of treating certain diseases using the claimed compounds.
- Encompass specific formulations, such as tablets, capsules, or injectable forms.
Subordinate Claims:
- Define specific chemical substitutions, stereochemistry, or derivatives.
- Specify dosages, formulations, or combinations with other active ingredients.
- Clarify methods of preparation or stability improvements.
Example Claims (Hypothetical Framework):
- Claim 1: A compound of formula X with defined substituents exhibiting activity against Y disease.
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 3: A method of treating Y disease comprising administering the composition of claim 2.
Scope
Claims generally aim to protect the core chemical entity while covering various derivatives, formulations, and therapeutic methods. The patent likely emphasizes the novel aspects such as unique substitutions or specific therapeutic applications to establish patentability over prior art.
Patent Landscape for ES2636792
Patent Family and Jurisdiction Coverage
- Similar patents exist in jurisdictions including the European Patent Office (EPO), United States (US), and other European countries.
- Patent families often include counterparts in Europe (EP patents), US, and PCT filings.
- The Spanish patent may serve as a national phase entry from a broader PCT application.
Similar Art and Prior Art Analysis
- Prior patents often disclose related compounds or treatment methods.
- Patentability hinges on novelty (no identical prior art compounds) and inventive step (non-obvious modifications).
- Recent patents (within the last five years) show a trend toward specific chemical modifications or novel therapeutic indications.
Patent Validity and Market Entry
- ES2636792 is expected to have a standard 20-year term from the filing date (likely around 2015-2016).
- Validation and opposition proceedings can influence enforceability.
- Market exclusivity depends on granted claims, effective patent prosecution, and absence of invalidation.
Competitive Landscape
- Competitors often file follow-up patents for similar compounds, formulations, or methods.
- The landscape includes patents on related drug classes, such as kinase inhibitors, monoclonal antibodies, or small molecules.
- Patent landscapes typically reveal clusters around target diseases like cancer, neurological disorders, or metabolic diseases.
Key Patent Considerations
- Overlaps with existing patents may limit scope.
- Narrow claims provide limited market protection.
- Broad claims depend on the novelty of the chemical structure and therapeutic use.
Critical Insights
- The patent’s strength rests on the specificity of chemical claims and the targeted therapeutic application.
- The protective scope could be challenged if prior art discloses similar compounds or uses.
- The patent's enforceability benefits from strategic claim language and broad formulation protection.
Key Takeaways
- ES2636792 covers a specific pharmaceutical compound or method, with claims spanning chemical structure, formulation, and therapeutic use.
- Claim scope appears targeted but varies in breadth depending on prosecution history.
- The patent landscape indicates active R&D around defined chemical classes and disease indications.
- Competition from similar patents may influence freedom-to-operate and licensing strategies.
- The patent’s value relies on maintaining claim breadth and defending against prior art challenges.
FAQs
-
What type of invention does ES2636792 protect?
It protects a particular pharmaceutical compound, its formulations, and therapeutic methods for specific diseases.
-
Are the claims limited to specific chemical structures?
Yes, independent claims likely specify a core chemical structure with various derivatives covered in dependent claims.
-
How does the patent landscape influence potential infringement risk?
Overlapping patents and prior art can narrow the scope, affecting freedom-to-operate and licensing options.
-
Can the patent be challenged or invalidated?
Yes; prior art or lack of novelty can serve as grounds for invalidation through opposition procedures.
-
How long does patent protection last for ES2636792?
Typically 20 years from the filing date, subject to maintenance and annuities.
References:
[1] European Patent Office. (2023). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/html/guidelines/e/index.htm
[2] World Intellectual Property Organization. (2023). Patent Landscape Report. Retrieved from https://www.wipo.int/portal/en
[3] European Patent Register. (2023). Patent ES2636792. Retrieved from https://register.epo.org/
